Jacques Fellay

EPFL SV GHI UPFELLAY
AAB 2 40 (Bâtiment AAB)
Station 19
CH-1015 Lausanne

Expertise

Human genomics of infectious diseases - Immunogenetics - Virus-host interactions - Translational genomics - Personalized health

Mission

Human genetic variation plays a key role in modulating immunity and determining individual outcomes after exposure to infectious agents. The mission of our laboratory is to contribute to a better understanding of inter-individual differences in response to infections, using a range of contemporary genomic tools. Approaches include genome-wide genotyping and association analysis, exome/genome sequencing and transcriptomics.
Jacques Fellay is a medical scientist with expertise in human genomics, infectious diseases, and personalized health. He obtained his MD from the University of Lausanne in 2002 and his PhD from University of Utrecht. After a clinical training in infectious diseases in Switzerland and a 4-years postdoctoral fellowship at Duke University, he joined the EPFL in April 2011 with an SNF Professorship. On top of his EPFL position, Jacques is also Head of Precision Medicine at the University Hospital (CHUV) in Lausanne, Group Leader at the Swiss Institute of Bioinformatics (SIB), Faculty member at the Swiss School of Public Health (SSPH ), and Chief Scientist at the Health2030 Genome Center at Campus Biotech in Geneva.

Awards

National Latsis Prize

Latsis foundation

2012

Leenaards Prize for translational medical research

Leenaards foundation

2015

Excellence in Basic Research Award

Swiss Society for Infectious Diseases

2017

« Divisionnaire F.-K. Rünzi » Foundation Award

2013

Infoscience

Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation

Z. M. XuG. E. GnouamoziS. RuegerP. R. SheaM. Buti  et al.

American Journal Of Human Genetics. 2024-06-06. DOI : 10.1016/j.ajhg.2024.04.013.

Diagnostic accuracy of a sequence-specific Mtb-DNA hybridization assay in urine: a case-control study including subclinical TB cases

Y. TschanM. SasamaloH. HizaJ. FellayS. Gagneux  et al.

Microbiology Spectrum. 2024-05-08. DOI : 10.1128/spectrum.00426-24.

Bacterial diversity dominates variable macrophage responses of tuberculosis patients in Tanzania

H. HizaM. ZwyerJ. HellaA. ArbuesM. Sasamalo  et al.

Scientific Reports. 2024-04-23. DOI : 10.1038/s41598-024-60001-0.

A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergy

A. Y. ChongN. BrennerA. Jimenez-KaufmannA. CortesM. Hill  et al.

American Journal Of Human Genetics. 2024-02-01. DOI : 10.1016/j.ajhg.2023.12.013.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (vol 15, 22, 2023)

D. MatuozzoE. TalouarnA. MarchalP. ZhangJ. Manry  et al.

Genome Medicine. 2024-01-06. DOI : 10.1186/s13073-023-01278-0.

Prevalence of actionable pharmacogenetic variants in a Swiss hospital cohort

F. HodelM. De MinC. ThorballJ. Fellay

2024-01-01. 56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, SCOTLAND, JUN 10-13, 2023. p. 700-700.

Inborn errors of type I interferon immunity in patients with severe acute hepatitis E

A. SaadatJ. GouttenoireD. MoradpourJ. FellayM. F. Christinet

2024-01-01. 56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, SCOTLAND, JUN 10-13, 2023. p. 451-451.

Prevalence of clonal hematopoiesis in people living with HIV

V. TimoninaK. PopadinJ. Fellay

2024-01-01. 56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, SCOTLAND, JUN 10-13, 2023. p. 443-444.

The impact of human genetics on Mycobacterium tuberculosis intra-host evolution

Z. M. XuM. ZwyerD. BritesH. HizaM. Reinhard  et al.

2024-01-01. 56th Annual Conference of the European-Society-of-Human-Genetics (ESHG), Glasgow, SCOTLAND, JUN 10-13, 2023. p. 346-346.

The HLA-B*57:01 allele corresponds to a very large MHC haploblock likely explaining its massive effect for HIV-1 elite control

M. RahmouniL. De MarcoJ.-L. SpadoniM. TisonR. Medina-Santos  et al.

Frontiers In Immunology. 2023-12-11. DOI : 10.3389/fimmu.2023.1305856.

Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E

A. SaadatJ. GouttenoireP. RipellinoD. SemelaS. Amar  et al.

Hepatology. 2023-12-08. DOI : 10.1097/HEP.0000000000000701.

Predicting type 2 diabetes risk before and after solid organ transplantation using polygenic scores in a Danish cohort

Q. dos SantosP. LeungC. W. ThorballB. LedergerberJ. Fellay  et al.

Frontiers In Molecular Biosciences. 2023-12-07. DOI : 10.3389/fmolb.2023.1282412.

Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy

A. GhasemiA. Martinez-UsatorreL. LiM. HichamA. N. T. Guichard  et al.

Nature Cancer. 2023-11-23. DOI : 10.1038/s43018-023-00668-y.

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

T. Le VoyerA. V. ParentX. LiuA. CederholmA. Gervais  et al.

Nature. 2023-11-08. DOI : 10.1038/s41586-023-06717-x.

Inborn Errors of Type I Interferon Immunity in Patients with Severe Acute Hepatitis E

A. SaadatJ. GouttenoireP. RipellinoD. SemelaS. Amar  et al.

2023-09-11. p. 14S-14S.

Africa-specific human genetic variation near CHD1L associates with HIV-1 load

P. J. J. McLarenI. PorrecaG. IaconisH. P. MokS. Mukhopadhyay  et al.

Nature. 2023-08-02. DOI : 10.1038/s41586-023-06370-4.

Variation in African genomes linked to control of HIV

P. J. McLarenJ. Fellay

Nature. 2023-08-02. DOI : 10.1038/d41586-023-02277-2.

A metagenome-wide association study of HIV disease progression in HIV controllers

L. M. RealM. E. SaezA. Corma-GomezA. Gonzalez-PerezC. Thorball  et al.

Iscience. 2023-07-21. DOI : 10.1016/j.isci.2023.107214.

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in & SIM;40% of patients

A. GervaisF. RovidaM. A. AvanziniS. CroceA. Marchal  et al.

Journal Of Experimental Medicine. 2023-06-22. DOI : 10.1084/jem.20230661.

Multiancestry sex-stratified genomic associations with HIV viral load and controller status from the ICGH

C. VergaraJ. F. TuffJ. Int Collaboration Genomics HIV ICGHJ. FellayP. Duggal  et al.

Jci Insight. 2023-06-08. DOI : 10.1172/jci.insight.170068.

Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study

J. M. SchwenkeC. W. ThorballI. C. SchoepfL. RyomB. Hasse  et al.

Journal Of Infectious Diseases. 2023-05-24. DOI : 10.1093/infdis/jiad179.

A polygenic risk score to predict sudden cardiac arrest in patients with cardiovascular disease

E. PorcuC. ThorballA. P. PorrettaE. PruvotK. Wiskott  et al.

2023-05-11. 55th European-Society-of-Human-Genetics (ESHG) Conference, Vienna, AUSTRIA, JUN 11-14, 2022. p. 691-691.

Host genomic susceptibility to severe respiratory syncytial virus infection

A. SaadatD. LawlessJ. Fellay

2023-05-11. 55th European-Society-of-Human-Genetics (ESHG) Conference, Vienna, AUSTRIA, JUN 11-14, 2022. p. 163-164.

A polygenic risk score improves the prediction of cardiovascular risk associated with obstructive sleep-apnoea

C. ThorballM. BergerG. SolelhacA. WaeberC. Redin  et al.

2023-05-11. 55th European-Society-of-Human-Genetics (ESHG) Conference, Vienna, AUSTRIA, JUN 11-14, 2022. p. 145-146.

Secondary structure of the human mitochondrial genome affects formation of deletions

V. ShamanskiyA. A. MikhailovaE. O. TretiakovK. UshakovaA. G. Mikhailova  et al.

Bmc Biology. 2023-05-08. DOI : 10.1186/s12915-023-01606-1.

Viral Genetic Determinants of Prolonged Respiratory Syncytial Virus Infection Among Infants in a Healthy Term Birth Cohort

D. LawlessC. G. McKennanS. R. DasT. JunierZ. M. Xu  et al.

Journal Of Infectious Diseases. 2023-05-01. DOI : 10.1093/infdis/jiac442.

Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years

I. C. SchoepfA. Esteban-CantosC. W. ThorballB. RodesP. Reiss  et al.

Lancet Healthy Longevity. 2023-05-01. DOI : 10.1016/S2666-7568(23)00037-5.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

D. MatuozzoE. TalouarnA. MarchalP. ZhangJ. Manry  et al.

Genome Medicine. 2023-04-05. DOI : 10.1186/s13073-023-01173-8.

Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania

M. ZwyerL. RutaihwaE. WindelsJ. HellaF. Menardo  et al.

Plos Pathogens. 2023-04-01. DOI : 10.1371/journal.ppat.1010893.

Associations of genetic and infectious risk factors with coronary heart disease

F. HodelZ. M. XuC. W. ThorballR. de la HarpeP. Letang-Mathieu  et al.

Elife. 2023-02-14. DOI : 10.7554/eLife.79742.

Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

E. F. AveryJ. N. KleynhansB. LedergerberI. C. SchoepfC. W. Thorball  et al.

Clinical Infectious Diseases. 2023-01-23. DOI : 10.1093/cid/ciad033.

Combining European and US risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study

R. de La HarpeC. W. ThorballC. RedinS. FournierO. Mueller  et al.

European Journal Of Preventive Cardiology. 2023-01-18. DOI : 10.1093/eurjpc/zwad012.

Multivalent Virucidal Antivirals: Synthesis, Mechanisms of Action, and Immune-stimulating Effects

Y. Zhu / F. Stellacci (Dir.)

Lausanne, EPFL, 2023. DOI : 10.5075/epfl-thesis-10366.

Genetic features and genomic targets of human KRAB-zinc finger proteins

J. de Tribolet-HardyC. W. ThorballR. ForeyE. PlanetJ. Duc  et al.

Genome Research. 2023. DOI : 10.1101/gr.277722.123.

Host-Pathogen Interactions Through the Genomic Lens

Z. M. Xu / J. Fellay (Dir.)

Lausanne, EPFL, 2023. DOI : 10.5075/epfl-thesis-10351.

Visual masking deficits in schizophrenia: a view into the genetics of the disease through an endophenotype

A. ShaqiriF. HodelJ. R. da CruzM. RoinishviliE. Chkonia  et al.

Translational Psychiatry. 2022-12-31. DOI : 10.1038/s41398-022-02275-4.

Variability of Primary Sjogren's Syndrome Is Driven by Interferon alpha and Interferon alpha Blood Levels Are Associated With the Class II HLA-DQ Locus

D. TrutschelP. BostX. MarietteV. BondetA. Llibre  et al.

Arthritis & Rheumatology. 2022-11-02. DOI : 10.1002/art.42265.

The combined impact of persistent infections and human genetic variation on C-reactive protein levels

F. HodelO. NaretC. BonnetN. BrennerN. Bender  et al.

Bmc Medicine. 2022-11-01. DOI : 10.1186/s12916-022-02607-7.

A mitochondria-specific mutational signature of aging: increased rate of A > G substitutions on the heavy strand

A. G. MikhailovaA. A. MikhailovaK. UshakovaE. O. TretiakovD. Iliushchenko  et al.

Nucleic Acids Research. 2022-09-21. DOI : 10.1093/nar/gkac779.

Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons Living With HIV: The Swiss HIV Cohort Study

I. C. SchoepfC. W. ThorballH. KovariB. LedergerberR. R. Buechel  et al.

Clinical Infectious Diseases. 2022-09-13. DOI : 10.1093/cid/ciac758.

A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits

S. NadeauC. W. ThorballR. KouyosH. F. GuenthardJ. Boeni  et al.

Molecular Biology And Evolution. 2022-08-03. DOI : 10.1093/molbev/msac163.

A Baseline Cellular Antiviral State Is Maintained by cGAS and Its Most Frequent Naturally Occurring Variant rs610913

J. KazmierskiC. ElsnerK. DoehnerS. XuA. Ducroux  et al.

Journal Of Immunology. 2022-08-01. DOI : 10.4049/jimmunol.2100685.

Improving polygenic prediction with genetically inferred ancestry

O. NaretZ. KutalikF. HodelZ. M. XuP. Marques-Vidal  et al.

Human Genetics And Genomics Advances. 2022-07-14. DOI : 10.1016/j.xhgg.2022.100109.

Host genomics of SARS-CoV-2 infection

C. RedinC. W. ThorballJ. Fellay

European Journal Of Human Genetics. 2022-06-30. DOI : 10.1038/s41431-022-01136-4.

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

J. ManryP. BastardA. GervaisT. Le VoyerJ. Rosain  et al.

Proceedings Of The National Academy Of Sciences Of The United States Of America. 2022-05-24. DOI : 10.1073/pnas.2200413119.

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group (vol 74, pg 1468, 2022)

H. NguyenB. HampelD. G. NunezM. BattegayA. Hachfeld  et al.

Clinical Infectious Diseases. 2022-04-27. DOI : 10.1093/cid/ciac242.

CD38 Expression by Antigen-Specific CD4 T Cells Is Significantly Restored 5 Months After Treatment Initiation Independently of Sputum Bacterial Load at the Time of Tuberculosis Diagnosis

H. HizaJ. HellaA. ArbuesM. SasamaloV. Misana  et al.

Frontiers In Medicine. 2022-04-15. DOI : 10.3389/fmed.2022.821776.

Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load

L. ZhaoC. WymantF. BlanquartT. GolubchikA. Gall  et al.

Virus Evolution. 2022-04-07. DOI : 10.1093/ve/veac022.

A polygenic risk score to predict sudden cardiac arrest in patients with cardiovascular disease

E. PorcuC. ThorballA. P. PorrettaE. PruvotK. Wiskott  et al.

2022-04-01. 50th European Mathematical Genetics Meeting (EMGM), Univ Cambridge, MRC Biostatist Unit, Cambridge, ENGLAND, April 21-22, 2022. p. 28-28.

Risk of mitochondrial deletions is affected by the global secondary structure of the mitochondrial genome

V. ShamanskiyA. A. MikhailovaK. UshakovaA. G. MikhailovaS. Oreshkov  et al.

2022-04-01. p. 438-439.

Increased CHIP prevalence amongst people living with HIV

K. PopadinA. G. BickC. W. ThorballM. M. UddinM. Zanni  et al.

2022-04-01. p. 75-75.

A billion-year trend of amino acid substitutions in the mitochondrial genome

A. A. MikhailovaA. G. MikhailovaV. ShamanskiyK. UshakovaA. Galieva  et al.

2022-04-01. p. 535-535.

Mitochondrial mutational spectrum in human cancers is sensitive to cellular hypoxia

A. G. MikhailovaP. LisitsaA. A. MikhailovaK. UshakovaE. Tretiakov  et al.

2022-04-01. p. 413-414.

A highly virulent variant of HIV-1 circulating in the Netherlands

C. WymantD. BezemerF. BlanquartL. FerrettiA. Gall  et al.

Science. 2022-02-04. DOI : 10.1126/science.abk1688.

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV

A. G. BickK. PopadinC. W. ThorballM. M. UddinM. Zanni  et al.

Scientific Reports. 2022-01-12. DOI : 10.1038/s41598-021-04308-2.

Using population-specific add-on polymorphisms to improve genotype imputation in underrepresented populations

Z. M. XuS. RuegerM. ZwyerD. BritesH. Hiza  et al.

Plos Computational Biology. 2022-01-01. DOI : 10.1371/journal.pcbi.1009628.

The interplay between human genetic variation, chronic inflammation and persistent infection: relevance for cardiovascular morbidity

F. A. S. Hodel / J. Fellay (Dir.)

Lausanne, EPFL, 2022. DOI : 10.5075/epfl-thesis-9518.

Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group

Huyen NguyenB. HampelD. G. NunezM. BattegayA. Hachfeld  et al.

Clinical Infectious Diseases. 2022. DOI : 10.1093/cid/ciab628.

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection

E. AndreakosL. AbelD. C. VinhE. KajaB. A. Drolet  et al.

Nature Immunology. 2022. DOI : 10.1038/s41590-021-01030-z.

Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years

I. C. SchoepfC. W. ThorballB. LedergerberN. A. KootstraP. Reiss  et al.

Journal Of Infectious Diseases. 2021-12-16. DOI : 10.1093/infdis/jiab603.

Human genomics of the humoral immune response against polyomaviruses

F. HodelA. Y. ChongP. ScepanovicZ. M. XuO. Naret  et al.

Virus Evolution. 2021-12-01. DOI : 10.1093/ve/veab058.

Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study

I. C. SchoepfC. W. ThorballB. LedergerberT. EngelM. Raffenberg  et al.

Clinical Infectious Diseases. 2021-11-01. DOI : 10.1093/cid/ciab521.

Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure

D. A. SmithA. MagriR. BowdenN. ChaturvediJ. Fellay  et al.

Nature Communications. 2021-10-20. DOI : 10.1038/s41467-021-25649-6.

Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption

D. FroelicherJ. R. Troncoso-PastorizaJ. L. RaisaroM. A. CuendetJ. S. Sousa  et al.

Nature Communications. 2021-10-11. DOI : 10.1038/s41467-021-25972-y.

A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response

Y. LuoM. KanaiW. ChoiX. LiS. Sakaue  et al.

Nature Genetics. 2021-10-01. DOI : 10.1038/s41588-021-00935-7.

Immunological lessons from genome-wide association studies of infections

C. W. ThorballJ. FellayA. Borghesi

Current Opinion In Immunology. 2021-10-01. DOI : 10.1016/j.coi.2021.03.017.

Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths

P. BastardA. GervaisT. Le VoyerJ. RosainQ. Philippot  et al.

Science Immunology. 2021-08-01. DOI : 10.1126/sciimmunol.abl4340.

Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma

C. W. ThorballT. Oudot-MellakhN. EhsanC. HammerF. A. Santoni  et al.

Haematologica. 2021-08-01. DOI : 10.3324/haematol.2020.247023.

HIV-1 and human genetic variation

P. J. McLarenJ. Fellay

Nature Reviews Genetics. 2021-06-24. DOI : 10.1038/s41576-021-00378-0.

Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores

L. G. DietrichC. W. ThorballL. RyomF. BurkhalterB. Hasse  et al.

Journal Of Infectious Diseases. 2021-06-15. DOI : 10.1093/infdis/jiaa695.

Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link

H. NguyenC. W. ThorballJ. FellayJ. BoniS. Yerly  et al.

Elife. 2021-06-01. DOI : 10.7554/eLife.67388.

Revolutionizing Medical Data Sharing Using Advanced Privacy-Enhancing Technologies: Technical, Legal, and Ethical Synthesis

J. ScheibnerJ. R. Troncoso-PastorizaM. IencaJ. FellayE. Vayena  et al.

Journal Of Medical Internet Research. 2021-02-25. DOI : 10.2196/25120.

The influence of human genetic variation on Epstein–Barr virus sequence diversity

S. RüegerC. HammerA. LoetscherP. J. McLarenD. Lawless  et al.

Scientific Reports. 2021-02-25. DOI : 10.1038/s41598-021-84070-7.

Blood virosphere in febrile Tanzanian children

S. CordeyF. LaubscherM.-A. HartleyT. JunierK. Keitel  et al.

Emerging Microbes & Infections. 2021-01-01. DOI : 10.1080/22221751.2021.1925161.

The genetic architecture of complex human traits at the dawn of genomic medicine

O. N. M. Naret / J. Fellay (Dir.)

Lausanne, EPFL, 2021. DOI : 10.5075/epfl-thesis-8464.

Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles

S. BenetC. GalvezF. DrobniewskiI. KontsevayaL. Arias  et al.

Journal Of Extracellular Vesicles. 2021-01-01. DOI : 10.1002/jev2.12046.

On the use of applied machine learning and digital infrastructure to leverage social media data in health and epidemiology

M. M. Müller / M. Salathé (Dir.)

Lausanne, EPFL, 2021. DOI : 10.5075/epfl-thesis-8283.

Genome-to-genome analysis identifies an Asian-specific variant in the gene encoding NTCP that leads to specific HBV escape mutations during chronic infection

Z. XuS. RuegerP. SheaM. ButiH. L. Y. Chan  et al.

2020-12-01. p. 316-317.

Human genomics of the humoral response against polyomaviruses

F. HodelA. Y. ChongP. ScepanovicC. W. ThorballZ. M. Xu  et al.

2020-12-01. p. 312-313.

An indel in the promoter region of NFKB1 confers protection against infection but increases risk of allergy

A. Y. ChongN. BrennerA. Jimenez KaufmannA. CortesR. Almond  et al.

2020-12-01. p. 311-312.

Using reference-fixed principal components to improve polygenic risk score prediction

O. NaretJ. Fellay

2020-12-01. p. 134-135.

Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment

C. W. ThorballA. BorghesiN. BachmannC. Von SiebenthalV. Vongrad  et al.

Jaids-Journal Of Acquired Immune Deficiency Syndromes. 2020-12-01. DOI : 10.1097/QAI.0000000000002473.

Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study

A. BorghesiJ. TrueckS. AsgariV. Sancho-ShimizuP. K. A. Agyeman  et al.

Clinical Infectious Diseases. 2020-11-15. DOI : 10.1093/cid/ciaa290.

HLA tapasin independence: broader peptide repertoire and HIV control

A. A. BashirovaM. ViardV. NaranbhaiA. GrifoniW. Garcia-Beltran  et al.

Proceedings Of The National Academy Of Sciences Of The United States Of America. 2020-11-10. DOI : 10.1073/pnas.2013554117.

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART

C. WanN. BachmannV. MitovF. BlanquartS. P. Cespedes  et al.

Nature Communications. 2020-11-02. DOI : 10.1038/s41467-020-19198-7.

Virosaurus A Reference to Explore and Capture Virus Genetic Diversity

A. GleizesF. LaubscherN. GuexC. IseliT. Junier  et al.

Viruses-Basel. 2020-11-01. DOI : 10.3390/v12111248.

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Q. ZhangP. BastardZ. LiuJ. Le PenM. Moncada-Velez  et al.

Science. 2020-10-23. DOI : 10.1126/science.abd4570.

Designing a Tanzanian Specific SNP Array Add-On to Capture Population-Specific Genetic Variations and to Improve Genotype Imputation

Z. XuS. RueegerU. PortevinS. GagneuxJ. Fellay

2020-07-01. 48th European Mathematical Genetics Meeting (EMGM), Lausanne, SWITZERLAND, Apr 16-17, 2020. p. 227-227. DOI : 10.1159/000507248.

Susceptibility to infection in early life: a growing role for human genetics

A. BorghesiA. MarzolloA. MichevJ. Fellay

Human Genetics. 2020-06-01. DOI : 10.1007/s00439-019-02109-2.

Exploring the interactions between the human and viral genomes

J. FellayV. Pedergnana

Human Genetics. 2020-06-01. DOI : 10.1007/s00439-019-02089-3.

Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland

J. C. LemaitreF. J. Perez-SaezA. S. AzmanA. RinaldoJ. Fellay

Swiss Medical Weekly. 2020-05-30. DOI : 10.4414/smw.20295.

HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation

J. AroraF. PieriniP. J. McLarenM. CarringtonJ. Fellay  et al.

Molecular Biology And Evolution. 2020-03-01. DOI : 10.1093/molbev/msz249.

Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate

L. G. DietrichC. BarceloC. W. ThorballL. RyomF. Burkhalter  et al.

Clinical Infectious Diseases. 2020-03-01. DOI : 10.1093/cid/ciz280.

SPHN/PHRT - MedCo in Action: Empowering the Swiss Molecular Tumor Board with Privacy-Preserving and Real-Time Patient Discovery

J. L. RaisaroJ. R. Troncoso-PastorizaS. PradervandM. CuendetM. Misbach  et al.

2020-01-01. 30th Medical Informatics Europe (MIE) Conference, Geneva, SWITZERLAND, Apr, 2020. p. 1161-1162. DOI : 10.3233/SHTI200345.

GenoShare: Supporting Privacy-Informed Decisions for Sharing Individual-Level Genetic Data

J. L. RaisaroJ. R. Troncoso-PastorizaY. El-ZeinM. HumbertC. Troncoso  et al.

2020-01-01. 30th Medical Informatics Europe (MIE) Conference, Geneva, SWITZERLAND, Apr, 2020. p. 238-241. DOI : 10.3233/SHTI200158.

Data protection and ethics requirements for multisite research with health data: a comparative examination of legislative governance frameworks and the role of data protection technologies

J. ScheibnerM. IencaS. KechagiaJ. R. Troncoso-PastorizaJ. L. Raisaro  et al.

Journal Of Law And The Biosciences. 2020-01-01. DOI : 10.1093/jlb/lsaa010.

Contact networks across ages: computational analysis of epidemiological dynamics

G. Lazzari / M. Salathé (Dir.)

Lausanne, EPFL, 2020. DOI : 10.5075/epfl-thesis-7482.

Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy

C. BarceloM. GuidiC. W. ThorballC. HammerA. Chaouch  et al.

Open Forum Infectious Diseases. 2020-01-01. DOI : 10.1093/ofid/ofz464.

COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation

S. MarcelA. L. ChristianN. RichardS. SilviaH. Emma  et al.

Swiss Medical Weekly. 2020-03-19. DOI : 10.4414/smw.2020.20225.

HIV host genomics in the era of effective antiretroviral therapy

C. A. W. Thorball / J. FellayD. Trono (Dir.)

Lausanne, EPFL, 2020. DOI : 10.5075/epfl-thesis-10132.

Teaching & PhD

PhD Students

Lisa Mathilde Julia Fournier, Valeriia Timonina, Chaimae El Houjjaji, Mariam Ait Oumelloul, Simon Tang, Emmanuelle Marie Mohbat, Miranda Linnéa Carlsson

Past EPFL PhD Students

Samira Asgari, Petar Scepanovic, Christian Axel Wandall Thorball, Olivier Naret, Flavia Aurelia Hodel, Zhi Ming Xu, Ali Saadat Varnosfaderanii

Past EPFL PhD Students as codirector

Zhicong Huang

Courses

Genomic solutions to sustainable development

BIO-312

The course explores how genomic technologies can contribute to achieving the UN Sustainable Development Goals. Students will learn how genomics impacts healthcare, agriculture, energy, and environmental conservation through lectures, case studies, and practical projects.

New tools & research strategies in personalized health

BIO-491

This course introduces the concept of personalized health, exploring its foundational technologies as well as the technological, legal, and ethical challenges the field currently faces. Strategies and approaches used to address these challenges will also be discussed.